In this 6-minute video, Edward Barnes, MD, from the University of North Carolina-Chapel Hill, reviews his talk on positioning therapeutics in IBD treatment from the September 12 virtual Advances In...
In this video, Cardiology Consultant Advisory Board Member Seth Baum, MD, overviews the intersection between nonalcoholic steatohepatitis and cardiovascular disease, which he calls the "next big threat to...
Michael Bloch, MD, talks about latest clinical data for PCSK9 inhibitors in lowering LDL-C and cardiovascular events, current evidence for the optimum LDL-C goals for patients with hypercholesterolemia, and...